World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
93
Citations
28456
World Ranking
10977
National Ranking
5644

Fredrick M. Wigley publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Fredrick M. Wigley sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 312 publications — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Fredrick M. Wigley D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Fredrick M. Wigley sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 93 D-Index — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Fredrick M. Wigley is affiliated with Johns Hopkins University in the United States. Their research primarily falls within the field of Medicine, with a focus on several subfields including Pathology and Forensic Medicine, Rheumatology, Pulmonary and Respiratory Medicine, Epidemiology, and Cardiology and Cardiovascular Medicine.

The scientist's work covers key topics related to systemic and inflammatory diseases, cardiovascular function, and respiratory conditions. The main topics addressed in their research include:

  • Systemic Sclerosis and Related Diseases
  • Inflammatory Myopathies and Dermatomyositis
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Pulmonary Hypertension Research and Treatments
  • Rheumatoid Arthritis Research and Therapies
  • Osteoarthritis Treatment and Mechanisms
  • Cardiovascular Function and Risk Factors

Fredrick M. Wigley has contributed to academic literature published across various venues. The most frequent publication venues are:

  • Arthritis & Rheumatology
  • Circulation
  • Arthritis Care & Research
  • Clinical and Experimental Rheumatology
  • Lara D. Veeken

Their recent papers include the following titles and publication years:

  • Treatment of Systemic Sclerosis-associated Interstitial Lung Disease: Evidence-based Recommendations. An Official American Thoracic Society Clinical Practice Guideline (2023) published in American Journal of Respiratory and Critical Care Medicine
  • Exercise right ventricular ejection fraction predicts right ventricular contractile reserve (2021) published in The Journal of Heart and Lung Transplantation
  • Relationship Between Gastrointestinal Transit, Medsger Gastrointestinal Severity, and University of California-Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract 2.0 Symptoms in Patients With Systemic Sclerosis (2020) published in Arthritis Care & Research
  • Protocol for a partially nested randomised controlled trial to evaluate the effectiveness of the scleroderma patient-centered intervention network COVID-19 home-isolation activities together (SPIN-CHAT) program to reduce anxiety among at-risk scleroderma patients (2020) published in Journal of Psychosomatic Research
  • Assessment of right ventricular reserve utilizing exercise provocation in systemic sclerosis (2021) published in International journal of cardiac imaging

Frequent co-authors collaborating with Fredrick M. Wigley include:

  • Ami A. Shah
  • Laura K. Hummers
  • Monica Mukherjee
  • Julie J. Paik
  • Steven Hsu

Best Publications

  • Cyclophosphamide versus placebo in scleroderma lung disease.

    Donald P. Tashkin;Robert Elashoff;Philip J. Clements;Jonathan Goldin

  • Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial.

    David B. Badesch;Victor F. Tapson;Michael D. McGoon;Bruce H. Brundage

  • Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial

    Donald P. Tashkin;Michael D. Roth;Philip J. Clements;Daniel E. Furst

  • A disease-specific activity index for Wegener's granulomatosis: Modification of the Birmingham Vasculitis Activity Score

    John H. Stone;Gary S. Hoffman;Peter A. Merkel;Yuan I. Min

  • Review: evidence that systemic sclerosis is a vascular disease.

    Marco Matucci-Cerinic;Bashar Kahaleh;Fredrick M. Wigley

  • Association of the Autoimmune Disease Scleroderma with an Immunologic Response to Cancer

    Christine G. Joseph;Erika Darrah;Ami A. Shah;Andrew D. Skora

  • Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus

    Timothy R.D.J. Radstake;Olga Y Gorlova;Blanca Rueda;Jose Ezequiel Martin

  • Clinical differences between idiopathic and scleroderma-related pulmonary hypertension

    Micah R. Fisher;Stephen C. Mathai;Hunter C. Champion;Reda E. Girgis

  • High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: Analysis of a two-year, double-blind, randomized, controlled clinical trial

    Philip J. Clements;Daniel E. Furst;Weng Kee Wong;Maureen Mayes

  • Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon

    Peter A. Merkel;Peter A. Merkel;Karen Herlyn;Richard W. Martin;Jennifer J. Anderson

  • Body Mass Index in Young Men and the Risk of Subsequent Knee and Hip Osteoarthritis

    Allan C. Gelber;Marc C. Hochberg;Lucy A. Mead;Nae Yuh Wang

  • Recombinant human relaxin in the treatment of scleroderma. A randomized, double-blind, placebo-controlled trial.

    James R. Seibold;Joseph H. Korn;Robert Simms;Phillip J. Clements

  • Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: High‐dose versus low‐dose penicillamine trial

    Philip J. Clements;Eric L. Hurwitz;Weng Kee Wong;James R. Seibold

  • Foot and ankle problems in rheumatoid arthritis.

    James Michelson;Mark Easley;Fredrick M. Wigley;David Hellmann

  • Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease.

    Stephen C. Mathai;Laura K. Hummers;Hunter C. Champion;Fredrick M. Wigley

  • Controlled double-blind trial of nifedipine in the treatment of Raynaud's phenomenon.

    Richard J. Rodeheffer;James A. Rommer;Fredrick Wigley;Craig R. Smith

  • Deficient Smad7 expression: A putative molecular defect in scleroderma

    Chunming Dong;Shoukang Zhu;Tao Wang;Woohyun Yoon

  • Mutations in Fibrillin-1 Cause Congenital Scleroderma: Stiff Skin Syndrome

    B. L. Loeys;B. L. Loeys;E. E. Gerber;D. Riegert-Johnson;S. Iqbal

  • Scleroderma Autoantigens Are Uniquely Fragmented by Metal-catalyzed Oxidation Reactions: Implications for Pathogenesis

    Livia Casciola-Rosen;Fredrick Wigley;Antony Rosen

  • Predictors and outcomes of scleroderma renal crisis: The high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial

    Paul J. DeMarco;Michael H. Weisman;James R. Seibold;Daniel E. Furst

Frequent Co-Authors

Maureen D. Mayes
Maureen D. Mayes The University of Texas at Austin
Robert A. Wise
Robert A. Wise Johns Hopkins University School of Medicine
John Varga
John Varga University of Michigan–Ann Arbor
Virginia D. Steen
Virginia D. Steen Georgetown University
Daniel E. Furst
Daniel E. Furst University of California, Los Angeles
Antony Rosen
Antony Rosen Johns Hopkins University School of Medicine
Livia Casciola-Rosen
Livia Casciola-Rosen Johns Hopkins University School of Medicine
Thomas A. Medsger
Thomas A. Medsger University of Pittsburgh
Paul M. Hassoun
Paul M. Hassoun Johns Hopkins University
Dinesh Khanna
Dinesh Khanna University of Michigan–Ann Arbor

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine isn’t limited to becoming a doctor—there are several related degrees that can open doors in healthcare. Many students consider a bachelors in health administration as a foundation for roles in hospital management, policy, or healthcare consulting. This degree is ideal for those interested in the organizational aspect of medicine.

For those looking to advance further, affordable affordable mha online programs can make it easier to specialize and take on leadership responsibilities. These programs often cater to working professionals and can be completed remotely.

Clinically inclined students may choose a 1 year dnp program online to become advanced practice nurses. These programs offer flexible, accelerated study options for experienced nurses to earn a doctoral degree.

Finally, those interested in medications, therapy management, and patient safety may explore pharmacy school online. These innovative online programs are making pharmacy education more accessible than ever before.

Best Scientists Citing Fredrick M. Wigley

Trending Scientists

Recently Published Articles